Cargando…

Right ventricular function declines prior to left ventricular ejection fraction in hypertrophic cardiomyopathy

BACKGROUND: The right ventricle (RV) in hypertrophic cardiomyopathy (HCM) tends to be neglected, as previous efforts have predominantly focused on examining the prognostic value of left ventricular (LV) abnormalities. The objectives of this study were to assess RV function in HCM, changes over time,...

Descripción completa

Detalles Bibliográficos
Autores principales: Mahmod, Masliza, Raman, Betty, Chan, Kenneth, Sivalokanathan, Sanjay, Smillie, Robert W., Samat, Azlan H. Abd, Ariga, Rina, Dass, Sairia, Ormondroyd, Elizabeth, Watkins, Hugh, Neubauer, Stefan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9190122/
https://www.ncbi.nlm.nih.gov/pubmed/35692049
http://dx.doi.org/10.1186/s12968-022-00868-y
_version_ 1784725726650433536
author Mahmod, Masliza
Raman, Betty
Chan, Kenneth
Sivalokanathan, Sanjay
Smillie, Robert W.
Samat, Azlan H. Abd
Ariga, Rina
Dass, Sairia
Ormondroyd, Elizabeth
Watkins, Hugh
Neubauer, Stefan
author_facet Mahmod, Masliza
Raman, Betty
Chan, Kenneth
Sivalokanathan, Sanjay
Smillie, Robert W.
Samat, Azlan H. Abd
Ariga, Rina
Dass, Sairia
Ormondroyd, Elizabeth
Watkins, Hugh
Neubauer, Stefan
author_sort Mahmod, Masliza
collection PubMed
description BACKGROUND: The right ventricle (RV) in hypertrophic cardiomyopathy (HCM) tends to be neglected, as previous efforts have predominantly focused on examining the prognostic value of left ventricular (LV) abnormalities. The objectives of this study were to assess RV function in HCM, changes over time, and association with clinical outcomes. METHODS: Two hundred and ninety HCM patients with preserved LV ejection fraction (LVEF ≥ 55%) and 30 age- and sex-matched controls underwent cardiovascular magnetic resonance (CMR). All patients were followed up for clinical events for a median duration of 4.4 years. Sixty-three patients had a follow-up CMR undertaken at a median interval of 5.4 years. Main study measures and outcomes were RV function (RV ejection fraction (RVEF) and RV strain) at baseline, temporal changes in RV function over time and prognostic value of RV dysfunction for predicting cardiovascular outcomes in HCM. RESULTS: When compared to controls, HCM patients exhibited lower RV and LV peak global longitudinal systolic strains on feature-tracking analysis of cine images, while RVEF and LVEF were within the normal range. On follow-up CMR, both RV and LV strain parameters decreased over time. RVEF decreased at follow-up (65 ± 7% to 62 ± 7%, P < 0.001) but the change in LVEF was not significant (68 ± 10% to 66 ± 8%, P = 0.30). On clinical follow up, reduced RVEF was an independent predictor of non-sustained ventricular tachycardia (NSVT) [HR 1.10 (95% CI 1.06–1.15), P < 0.001] and composite cardiovascular events (NSVT, stroke, heart failure hospitalisation and cardiovascular death) [HR 1.07 (95% CI 1.03–1.10), P < 0.001]. RV longitudinal strain was an independent predictor of NSVT [HR 1.05 (95% CI 1.01–1.09), P = 0.029]. Patients with RVEF < 55% showed an increased risk of NSVT and composite cardiovascular events. In contrast, LVEF and LV global longitudinal strain were not predictive of such events on multivariable analysis. CONCLUSIONS: In HCM, RV function, including RV strain, and LV strain decrease over time despite preserved LVEF. Reduction in RV but not LV function is associated with adverse cardiovascular outcomes. Assessing RV function in early HCM disease might have a role in risk stratification to prevent future cardiovascular events. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12968-022-00868-y.
format Online
Article
Text
id pubmed-9190122
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-91901222022-06-14 Right ventricular function declines prior to left ventricular ejection fraction in hypertrophic cardiomyopathy Mahmod, Masliza Raman, Betty Chan, Kenneth Sivalokanathan, Sanjay Smillie, Robert W. Samat, Azlan H. Abd Ariga, Rina Dass, Sairia Ormondroyd, Elizabeth Watkins, Hugh Neubauer, Stefan J Cardiovasc Magn Reson Research BACKGROUND: The right ventricle (RV) in hypertrophic cardiomyopathy (HCM) tends to be neglected, as previous efforts have predominantly focused on examining the prognostic value of left ventricular (LV) abnormalities. The objectives of this study were to assess RV function in HCM, changes over time, and association with clinical outcomes. METHODS: Two hundred and ninety HCM patients with preserved LV ejection fraction (LVEF ≥ 55%) and 30 age- and sex-matched controls underwent cardiovascular magnetic resonance (CMR). All patients were followed up for clinical events for a median duration of 4.4 years. Sixty-three patients had a follow-up CMR undertaken at a median interval of 5.4 years. Main study measures and outcomes were RV function (RV ejection fraction (RVEF) and RV strain) at baseline, temporal changes in RV function over time and prognostic value of RV dysfunction for predicting cardiovascular outcomes in HCM. RESULTS: When compared to controls, HCM patients exhibited lower RV and LV peak global longitudinal systolic strains on feature-tracking analysis of cine images, while RVEF and LVEF were within the normal range. On follow-up CMR, both RV and LV strain parameters decreased over time. RVEF decreased at follow-up (65 ± 7% to 62 ± 7%, P < 0.001) but the change in LVEF was not significant (68 ± 10% to 66 ± 8%, P = 0.30). On clinical follow up, reduced RVEF was an independent predictor of non-sustained ventricular tachycardia (NSVT) [HR 1.10 (95% CI 1.06–1.15), P < 0.001] and composite cardiovascular events (NSVT, stroke, heart failure hospitalisation and cardiovascular death) [HR 1.07 (95% CI 1.03–1.10), P < 0.001]. RV longitudinal strain was an independent predictor of NSVT [HR 1.05 (95% CI 1.01–1.09), P = 0.029]. Patients with RVEF < 55% showed an increased risk of NSVT and composite cardiovascular events. In contrast, LVEF and LV global longitudinal strain were not predictive of such events on multivariable analysis. CONCLUSIONS: In HCM, RV function, including RV strain, and LV strain decrease over time despite preserved LVEF. Reduction in RV but not LV function is associated with adverse cardiovascular outcomes. Assessing RV function in early HCM disease might have a role in risk stratification to prevent future cardiovascular events. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12968-022-00868-y. BioMed Central 2022-06-13 /pmc/articles/PMC9190122/ /pubmed/35692049 http://dx.doi.org/10.1186/s12968-022-00868-y Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Mahmod, Masliza
Raman, Betty
Chan, Kenneth
Sivalokanathan, Sanjay
Smillie, Robert W.
Samat, Azlan H. Abd
Ariga, Rina
Dass, Sairia
Ormondroyd, Elizabeth
Watkins, Hugh
Neubauer, Stefan
Right ventricular function declines prior to left ventricular ejection fraction in hypertrophic cardiomyopathy
title Right ventricular function declines prior to left ventricular ejection fraction in hypertrophic cardiomyopathy
title_full Right ventricular function declines prior to left ventricular ejection fraction in hypertrophic cardiomyopathy
title_fullStr Right ventricular function declines prior to left ventricular ejection fraction in hypertrophic cardiomyopathy
title_full_unstemmed Right ventricular function declines prior to left ventricular ejection fraction in hypertrophic cardiomyopathy
title_short Right ventricular function declines prior to left ventricular ejection fraction in hypertrophic cardiomyopathy
title_sort right ventricular function declines prior to left ventricular ejection fraction in hypertrophic cardiomyopathy
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9190122/
https://www.ncbi.nlm.nih.gov/pubmed/35692049
http://dx.doi.org/10.1186/s12968-022-00868-y
work_keys_str_mv AT mahmodmasliza rightventricularfunctiondeclinespriortoleftventricularejectionfractioninhypertrophiccardiomyopathy
AT ramanbetty rightventricularfunctiondeclinespriortoleftventricularejectionfractioninhypertrophiccardiomyopathy
AT chankenneth rightventricularfunctiondeclinespriortoleftventricularejectionfractioninhypertrophiccardiomyopathy
AT sivalokanathansanjay rightventricularfunctiondeclinespriortoleftventricularejectionfractioninhypertrophiccardiomyopathy
AT smillierobertw rightventricularfunctiondeclinespriortoleftventricularejectionfractioninhypertrophiccardiomyopathy
AT samatazlanhabd rightventricularfunctiondeclinespriortoleftventricularejectionfractioninhypertrophiccardiomyopathy
AT arigarina rightventricularfunctiondeclinespriortoleftventricularejectionfractioninhypertrophiccardiomyopathy
AT dasssairia rightventricularfunctiondeclinespriortoleftventricularejectionfractioninhypertrophiccardiomyopathy
AT ormondroydelizabeth rightventricularfunctiondeclinespriortoleftventricularejectionfractioninhypertrophiccardiomyopathy
AT watkinshugh rightventricularfunctiondeclinespriortoleftventricularejectionfractioninhypertrophiccardiomyopathy
AT neubauerstefan rightventricularfunctiondeclinespriortoleftventricularejectionfractioninhypertrophiccardiomyopathy